×

or


Overseeing the Unregulated Consent Norms in Novel Medical Treatments

Krishna Venkat | November 2019

A few weeks back, I had the opportunity of being a part of a panel discussion that covered a range […]

Read More

E-Pharmacies – What Could We Hope for in The Regulations

Krishna Venkat | September 2019

Online pharmacies, commonly referred to as “E-Pharmacies” remain at an interesting legal position in the Indian context. On the one […]

Read More

Data Analytics in the Healthcare Space – Issues to Consider

Krishna Venkat | August 2019

Data analytics in the healthcare space is a major commercial and social opportunity for stakeholders to transform healthcare delivery capabilities […]

Read More

E-Pharmacies and the Missing Link in the Drugs & Cosmetics Act 1940

Krishna Venkat | July 2019

July 2019 is certainly going to be remembered as an interesting time in the evolution of e-pharmacy regulations, with e-pharmacy […]

Read More

The FDC Ban – What could one expect from the DTAB Constituted Sub-Committee?

Krishna Venkat | June 2019

The Government of India continues its keen study on the merits of the use of fixed dose combinations (“FDCs”) in […]

Read More

The DTAB Recommendations on a Regulatory Framework for Medical Devices

Krishna Venkat | May 2019

In April of this year, the Drugs Technical Advisory Board (“DTAB”) deliberated on the issue of creating a roadmap for […]

Read More